Funded Startups in Gelderland
Among the 35 disclosed rounds shown for Gelderland, the largest disclosed amount is Allego’s $150M post-IPO equity round on 2022-03-17.
Among the 35 disclosed rounds shown for Gelderland, the largest disclosed amount is Allego’s $150M post-IPO equity round on 2022-03-17. The next-highest disclosed amounts are $28M (Revyve on 2025-09-23 and ScreenPoint Medical on 2021-07-27) and $25M (Micreos on 2022-10-25), making Allego a clear outlier relative to the rest of the list’s upper range.
Most of the activity clusters in the city of Nijmegen (e.g., CardiacBooster $11M on 2025-08-07; Khondrion $6M on 2025-05-06; QurieGen $2M on 2025-04-08; Thirona $5M on 2023-09-11; Pleco Therapeutics $17M on 2022-09-06), while Wageningen appears repeatedly for biotechnology and agriculture (Revyve $28M on 2025-09-23; Solynta $23M on 2025-07-18; Micreos $25M on 2022-10-25). Chronologically, rounds span 2020-05-18 (GATT Technologies $11M) through the most recent 2025-09-23 (Revyve $28M).
Most recent rounds
35 shownRelated listings
Frequently asked
What stands out on deal size for Gelderland in this list, and how does the top round compare to the rest?
Allego’s $150M post-IPO equity round on 2022-03-17 is far above the other disclosed amounts; the next tier tops out around $28M (Revyve on 2025-09-23 and ScreenPoint Medical on 2021-07-27) and $25M (Micreos on 2022-10-25). That gap makes Allego the dominant size outlier in these 35 rows.
Do specific cities or geographies show up more often than others across recent rounds?
Nijmegen is the most consistent city in the dataset, with multiple entries across years and stages such as CardiacBooster ($11M, 2025-08-07), Khondrion ($6M, 2025-05-06), Thirona ($5M, 2023-09-11), and Pleco Therapeutics ($17M, 2022-09-06). Wageningen also clusters repeatedly for life-science and ag-focused names like Revyve ($28M, 2025-09-23) and Solynta ($23M, 2025-07-18).
How much of the activity falls into the most recent window (roughly the last 90 days of the latest date shown)?
Using the latest date shown (2025-09-23, Revyve $28M), the 90-day window covers entries from 2025-06-24 onward. Within that range, disclosed rounds include Rival Foods ($12M, 2025-06-18 is outside the window), plus Solynta ($23M, 2025-07-18), CardiacBooster ($11M, 2025-08-07), and Revyve itself on 2025-09-23; some entries in late June/May have undisclosed amounts (e.g., ChargeNet on 2025-05-19).
What stage and classification patterns are most common in this list?
“Series Unknown” appears frequently (e.g., CardiacBooster on 2025-08-07; Khondrion on 2025-05-06; SolarDuck on 2023-12-21), and there are also several “undisclosed” amounts (ChargeNet on 2025-05-19; Morssinkhof Rymoplast on 2025-01-15; Salesupply on 2025-01-01; plus others). By contrast, the explicit largest-ticket equity in this snapshot is a named category only for Allego (“Post-IPO Equity” at $150M on 2022-03-17).
Are there sector outliers compared with the rest of the sector mix?
Biotechnology and related life-sciences recur (Revyve $28M, 2025-09-23; Alveron Pharma $5M, 2024-12-06; Micreos $25M, 2022-10-25), but the clearest sector outlier by size is Allego in Transportation with $150M on 2022-03-17, dominating the overall disclosed range. Energy is another notable cluster across multiple years (e.g., SolarDuck $16M, 2023-12-21; New Sources Energy $520K, 2024-12-19), though it does not approach the top-end outlier.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.